$DXC

DXC Technology in talks to sell insurance software unit to Eldridge Industries for $2.4 bn

DXC Technology is in talks to sell its insurance software unit to Eldridge Industries for $2.4 bn. The division could be merged with Eldridge's Zinnia platform. DXC aims to simplify its portfolio amid declining revenue. Eldridge seeks to expand its insurance technology operations. No final agreement has been reached.

Original reporting
Published Oct 21, 2026, 9:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 1:04 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
DXC Technology in talks to sell insurance software unit to Eldridge Industries for $2.4 bn — source image
Decision brief

The 30-second read

$DXCBullishHigh
01

Why it matters

The transaction provides a cash boost and strategic focus, likely improving DXC's valuation metrics.

02

Market read

A $2.4 bn sale of a major insurance‑software unit is a material M&A event that can move DXC's stock and affect the broader insurance‑tech sector.

03

What to watch

Integration risk for Eldridge and potential loss of cross‑selling opportunities.

Relevance 9/10Novelty 9/10Timing: immediate

Background

DXC has been trimming its portfolio after years of declining revenue; this is its largest divestiture to date.

Company-level read

Ticker impact

$DXCBullishHigh confidence
Context

DXC Technology is negotiating to sell its insurance software and services division to Eldridge Industries for approximately $2.4 bn.

Expected impact

potential upside as the market prices in portfolio simplification and cash infusion.

Evidence & confidence

A large‑scale $2.4 bn sale of a non‑core unit is material and new, giving traders a clear catalyst.

Market effects

Insurance‑software providers may see consolidation pressure and valuation re‑rating.

U.S. IT services sector could benefit from DXC's portfolio simplification.

The deal may influence global insurance‑tech partnerships and M&A activity.

Counterpoint

The sale could signal deeper weakness in DXC's core business, prompting a sell‑off.

Key entities

  • DXC Technology

    U.S. IT services provider.

  • Eldridge Industries

    Potential acquirer planning to combine the unit with its Zinnia platform.

Related articles

$DXCHighAI 8/10

DXC in Advanced Talks to Sell Insurance Software Unit

DXC Technology is in advanced talks to sell its insurance software unit to Eldridge Industries for approximately $2.4 billion, according to sources. The sale would simplify DXC's portfolio and allow Eldridge to combine the unit with its existing Zinnia platform. Neither company has commented on the reports.

$DXCMedAI 8/10

Stifel maintains Hold on DXC Technology stock amid unit sale reports

Stifel reiterated a Hold rating and $10.50 price target on DXC Technology (NYSE:DXC) amid reports of potential insurance unit sale to Eldridge for $2.4B. DXC's insurance unit generated $1.3B in LTM revenue. DXC's stock trades at $14.26, with a P/E ratio of 20.18. The company reported mixed Q1 2027 results, missing EPS estimates but beating revenue forecasts. TD Cowen raised its price target to $12.00, maintaining a Hold rating.

$DXCMed

Why DXC (DXC) Stock Is Trading Up Today

DXC Technology (NYSE: DXC) shares rose 4.6% after announcing a partnership with LangChain to deploy AI agents. The collaboration leverages DXC's OASIS platform, which reportedly reduced resolution times by 95% in over 500 use cases. The stock later settled at $12.97, up 3.4%. DXC is down 7.9% year-to-date, trading 16% below its 52-week high.

$DXCMed

Is DXC Technology (DXC) Fairly Valued As Leadership Changes Put Execution Back In Focus?

DXC Technology (DXC) appointed new leaders for key business units. Shares closed at $11.39, up 3.17% in one day but down 19.11% year-to-date and 68.33% over five years. Analysts debate its valuation, with some calling it undervalued at $11.43 based on discounted cash flow analysis, citing strong bookings momentum. However, risks include declining revenue and profitability challenges.

$KDLow

Q2 Rundown: Kyndryl (NYSE:KD) Vs Other IT Services & Consulting Stocks

Kyndryl (KD) reported Q2 revenue of $3.62B, down 3.3% YoY, missing estimates by 0.7% but beating EPS. Gartner (IT) reported $1.68B revenue, up 1.8% YoY, beating estimates. Accenture (ACN) reported $18.72B revenue, up 5.6% YoY, in line with estimates but missed guidance. IBM (IBM) reported $17.16B revenue, up 1.1% YoY, missing estimates by 1.5%. DXC (DXC) reported $3.00B revenue, down 5.1% YoY, in line with estimates but missed EPS.